165 related articles for article (PubMed ID: 37856835)
1. Somatic Mutations: The Next Frontier in Demystifying Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis?
Yan X; Kaminski N
Am J Respir Crit Care Med; 2023 Dec; 208(11):1150-1151. PubMed ID: 37856835
[No Abstract] [Full Text] [Related]
2. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Faner R; Rojas M; Macnee W; Agustí A
Am J Respir Crit Care Med; 2012 Aug; 186(4):306-13. PubMed ID: 22582162
[TBL] [Abstract][Full Text] [Related]
3. Chair's Summary: Mechanisms of Exacerbation of Lung Diseases.
Nicod LP; Kolls JK
Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2(Suppl 2):S112-4. PubMed ID: 26595726
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.
Ryter SW; Rosas IO; Owen CA; Martinez FJ; Choi ME; Lee CG; Elias JA; Choi AMK
Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S266-S272. PubMed ID: 30759019
[TBL] [Abstract][Full Text] [Related]
5. Clonal Somatic Mutations in Chronic Lung Diseases Are Associated with Reduced Lung Function.
Yun JH; Khan MAW; Ghosh A; Hobbs BD; Castaldi PJ; Hersh CP; Miller PG; Cool CD; Sciurba F; Barwick L; Limper AH; Flaherty K; Criner GJ; Brown K; Wise R; Martinez F; Silverman EK; DeMeo D; ; Cho MH; Bick AG
Am J Respir Crit Care Med; 2023 Dec; 208(11):1196-1205. PubMed ID: 37788444
[No Abstract] [Full Text] [Related]
6. Mitochondrial dysfunction and chronic lung disease.
Fang T; Wang M; Xiao H; Wei X
Cell Biol Toxicol; 2019 Dec; 35(6):493-502. PubMed ID: 31119467
[TBL] [Abstract][Full Text] [Related]
7. Genetic Susceptibility to Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis: The Missing Link?
Polverino F
Am J Respir Cell Mol Biol; 2023 May; 68(5):482-484. PubMed ID: 36753719
[No Abstract] [Full Text] [Related]
8. [Perioperative Pulmonary Rehabilitation for Lung Cancer Surgeries in Patients with Poor Pulmonary Function].
Sano Y
Kyobu Geka; 2016 Jan; 69(1):41-6. PubMed ID: 26975642
[TBL] [Abstract][Full Text] [Related]
9. Introduction to the pulmonary research group's symposium: Preclinical research in COPD and pulmonary fibrosis.
Williams CM; Lundblad LK
Pulm Pharmacol Ther; 2012 Aug; 25(4):255-6. PubMed ID: 22465563
[No Abstract] [Full Text] [Related]
10. Cell Death in the Lung: The Apoptosis-Necroptosis Axis.
Sauler M; Bazan IS; Lee PJ
Annu Rev Physiol; 2019 Feb; 81():375-402. PubMed ID: 30485762
[TBL] [Abstract][Full Text] [Related]
11. Nasal high flow and respiratory patterns: determinants of underlying lung functions--are complex interactions easily controlled?
Esquinas AM; Patel B; Dikmen Y
Respiration; 2013; 86(4):352. PubMed ID: 23989038
[No Abstract] [Full Text] [Related]
12. Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.
Nowak J; Hudzik B; Jastrzȩbski D; Niedziela JT; Rozentryt P; Wojarski J; Ochman M; Karolak W; Żegleń S; Gierlotka M; Gąsior M
Clin Respir J; 2018 Mar; 12(3):930-938. PubMed ID: 28052583
[TBL] [Abstract][Full Text] [Related]
13. Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis.
Corrado A; Carpagnano GE; Gaudio A; Foschino-Barbaro MP; Cantatore FP
Joint Bone Spine; 2010 Dec; 77(6):570-4. PubMed ID: 20547086
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension associated with chronic obstructive lung disease and idiopathic pulmonary fibrosis.
Adir Y; Harari S
Curr Opin Pulm Med; 2014 Sep; 20(5):414-20. PubMed ID: 25046428
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic pulmonary fibrosis is associated with increased impedance measures of reflux compared to non-fibrotic disease among pre-lung transplant patients.
Gavini S; Finn RT; Lo WK; Goldberg HJ; Burakoff R; Feldman N; Chan WW
Neurogastroenterol Motil; 2015 Sep; 27(9):1326-32. PubMed ID: 26176338
[TBL] [Abstract][Full Text] [Related]
16. Telomeres in lung disease.
Gansner JM; Rosas IO
Transl Res; 2013 Dec; 162(6):343-52. PubMed ID: 23618685
[TBL] [Abstract][Full Text] [Related]
17. Commonalities between the pro-fibrotic mechanisms in COPD and IPF.
Murray LA
Pulm Pharmacol Ther; 2012 Aug; 25(4):276-80. PubMed ID: 21983244
[TBL] [Abstract][Full Text] [Related]
18. Peak power estimated from 6-minute walk distance in Asian patients with idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Kozu R; Jenkins S; Senjyu H; Mukae H; Sakamoto N; Kohno S
Respirology; 2010 May; 15(4):706-13. PubMed ID: 20409022
[TBL] [Abstract][Full Text] [Related]
19. Proteinase-activated receptors in fibroproliferative lung disease.
José RJ; Williams AE; Chambers RC
Thorax; 2014 Feb; 69(2):190-2. PubMed ID: 24186921
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation.
Linden PA; Gilbert RJ; Yeap BY; Boyle K; Deykin A; Jaklitsch MT; Sugarbaker DJ; Bueno R
J Thorac Cardiovasc Surg; 2006 Feb; 131(2):438-46. PubMed ID: 16434276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
